Skin Autofluorescence, As a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque Psoriasis

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2018 Oct 27

PMID 30363704

Citations 10

Authors

Karolina Kopec-Pyciarz

Irena Makulska

Danuta Zwolinska

Lukasz Laczmanski

Wojciech Baran

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is currently regarded as a chronic systemic inflammatory disease associated with increased cardiovascular risk. Advanced glycation end products (AGEs) contribute to the development of atherosclerosis.

Objectives: The aim of the study was the assessment of skin autofluorescence (SAF), as a measure of AGE accumulation, in individuals suffering from chronic plaque psoriasis without any comorbid conditions.

Methods: A study group consisted of 70 patients with chronic plaque psoriasis without any comorbid conditions and 59 healthy controls, matched by age and gender. AGE accumulation was assessed by SAF (AGE Reader, DiagnOptics BV) which is a validated and noninvasive technique. Relations between SAF and some clinical and laboratory data were assessed.

Results: SAF was positively correlated with age both in patients with psoriasis and controls ( = 0.722, < 0.00001 and = 0.613, < 0.00001, respectively). There was significantly increased SAF in patients with psoriasis with elevated levels of C-reactive protein (CRP) and increased erythrocyte sedimentation rate (ESR) compared to controls ( < 0.00001; < 0.00001, respectively, after adjustment to age). Increased SAF was found in psoriatic patients with prediabetes (HbA1c 5.7-6.4%) compared to controls ( < 0.0012, after adjustment to age).

Conclusion: Systemic inflammation (increased CRP level), prediabetes, and aging may influence enhanced AGE accumulation in patients with psoriasis without any comorbidities. SAF may be considered as a useful, noninvasive method to identify patients with psoriasis at increased cardiovascular risk.

Citing Articles

Advanced glycation end product signaling and metabolic complications: Dietary approach.

Khan M, Ashfaq F, Alsayegh A, Hamouda A, Khatoon F, Altamimi T World J Diabetes. 2023; 14(7):995-1012.

PMID: 37547584 PMC: 10401445. DOI: 10.4239/wjd.v14.i7.995.

Advanced Glycation End Products and Psoriasis.

Maurelli M, Gisondi P, Girolomoni G Vaccines (Basel). 2023; 11(3).

PMID: 36992201 PMC: 10056603. DOI: 10.3390/vaccines11030617.

Concentrations of N-Carboxymethyllysine (CML), N-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients.

Damasiewicz-Bodzek A, Nowak A Biomolecules. 2022; 12(12).

PMID: 36551298 PMC: 9775373. DOI: 10.3390/biom12121870.

Biofilm Inhibiting Activity of Advanced Glycation Endproduct Crosslink Breaking and Glycation Inhibiting Compounds.

Haasbroek K, Yagi M, Yonei Y Antibiotics (Basel). 2022; 11(10).

PMID: 36290070 PMC: 9598957. DOI: 10.3390/antibiotics11101412.

Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations.

Augustin J, Wolf S, Stephan B, Augustin M, Andrees V PLoS One. 2022; 17(3):e0265741.

PMID: 35316303 PMC: 8939781. DOI: 10.1371/journal.pone.0265741.

References

Smit A, Smit J, Botterblom G, Mulder D . Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes. PLoS One. 2013; 8(6):e65592. PMC: 3672176. DOI: 10.1371/journal.pone.0065592. View

Couppe C, Dall C, Svensson R, Olsen R, Karlsen A, Praet S . Skin autofluorescence is associated with arterial stiffness and insulin level in endurance runners and healthy controls - Effects of aging and endurance exercise. Exp Gerontol. 2017; 91:9-14. DOI: 10.1016/j.exger.2017.02.002. View

Stitt A, He C, Friedman S, Scher L, Rossi P, Ong L . Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med. 1997; 3(9):617-27. PMC: 2230092. View

Noordzij M, Lefrandt J, Graaff R, Smit A . Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther. 2011; 13(2):165-70. DOI: 10.1089/dia.2010.0123. View

van Eupen M, Schram M, van Sloten T, Scheijen J, Sep S, van der Kallen C . Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study. Hypertension. 2016; 68(4):956-63. DOI: 10.1161/HYPERTENSIONAHA.116.07446. View

Boehncke W, Boehncke S, Tobin A, Kirby B . The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011; 20(4):303-7. DOI: 10.1111/j.1600-0625.2011.01261.x. View

Meerwaldt R, Lutgers H, Links T, Graaff R, Baynes J, Gans R . Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care. 2006; 30(1):107-12. DOI: 10.2337/dc06-1391. View

de Groot L, Hinkema H, Westra J, Smit A, Kallenberg C, Bijl M . Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther. 2011; 13(6):R205. PMC: 3334658. DOI: 10.1186/ar3538. View

Nienhuis H, Westra J, Smit A, Limburg P, Kallenberg C, Bijl M . AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity. 2009; 42(4):302-4. DOI: 10.1080/08916930902831746. View

10.

Wautier J, Guillausseau P . Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 2001; 27(5 Pt 1):535-42. View

11.

Yiu K, Yeung C, Chan H, Wong R, Tam S, Lam K . Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol. 2010; 164(3):514-20. DOI: 10.1111/j.1365-2133.2010.10107.x. View

12.

Januszewski A, Sachithanandan N, Karschimkus C, ONeal D, Yeung C, Alkatib N . Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabet Med. 2012; 29(6):726-33. DOI: 10.1111/j.1464-5491.2011.03562.x. View

13.

Weiss M, Erhard P, Wu Y, DeOreo P, Araki A, Glomb M . Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int. 2000; 57(6):2571-85. DOI: 10.1046/j.1523-1755.2000.00117.x. View

14.

Nienhuis H, de Leeuw K, Bijzet J, Smit A, Schalkwijk C, Graaff R . Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts. Rheumatology (Oxford). 2008; 47(10):1554-8. DOI: 10.1093/rheumatology/ken302. View

15.

Nagano M, Fukami K, Yamagishi S, Sakai K, Kaida Y, Matsumoto T . Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients. Nephrology (Carlton). 2010; 16(3):299-303. DOI: 10.1111/j.1440-1797.2010.01419.x. View

16.

Davidovici B, Sattar N, Prinz J, Jorg P, Puig L, Emery P . Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010; 130(7):1785-96. DOI: 10.1038/jid.2010.103. View

17.

Meerwaldt R, Hartog J, Graaff R, Huisman R, Links T, den Hollander N . Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16(12):3687-93. DOI: 10.1681/ASN.2005020144. View

18.

Schmidt A, Yan S, Wautier J, Stern D . Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999; 84(5):489-97. DOI: 10.1161/01.res.84.5.489. View

19.

Cohen A, Dreiher J, Shapiro Y, Vidavsky L, Vardy D, Davidovici B . Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol. 2008; 22(5):585-9. DOI: 10.1111/j.1468-3083.2008.02636.x. View

20.

Oleniuc M, Secara I, Onofriescu M, Hogas S, Voroneanu L, Siriopol D . Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence. Maedica (Bucur). 2012; 6(4):298-307. PMC: 3391948. View